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Background
Introduction
Major depressive disorder is one of the most common mental health problems 
encountered by primary care providers in the U.S. For people age 12 and older, 
prevalence is estimated at eight percent. The economic cost of depression has 
been estimated at $210.5 billion per year, attributed to both costs to the work 
place and medical costs. People who experience depression are at greater risk 
for suicide, an otherwise preventable death if depression can be recognized and 
adequately treated. For these reasons, depression screening has become an 
essential function within primary care practices both within Providence and 
nation-wide.1
Background Research and Literature Review
Multiple screening tools have been adopted to improving screening for 
depression including the Patient Health Questionnaire (PHQ), Hospital Anxiety 
and Depression Scales, Geriatric Depression Scale, and Edinburgh Postnatal 
Depression Scale. In addition to these validated tools, other previous attempts 
to increase depression screening have included advance administration through 
a patient portal or a written questionnaire, nurse administration during check in, 
or provider administration during clinical encounter.2
While each method has shown to have advantages and disadvantages 
depending on cost, ease of administration, and level of patient literacy, the 
PHQ-2 remains the standard for depression screening in most clinical settings. 
The PHQ-2, which screens patient’s for unipolar depression using two questions 
exploring feelings of depressed mood and anhedonia, is a validated screening 
tool with good sensitivity for detecting depression risk. A 2010 study involving 
2,642 patients in New Zealand showed that a PHQ-2 score of 2 or higher has a 
sensitivity of 86% and specificity of 78%.3 The ease of administering the two-
question survey along with the concrete sensitivity for detecting Major 
Depressive Disorder (MDD) has made the PHQ-2 widely adopted in primary 
care settings.  
A number of studies have shown varying approaches to improving depression 
screening in primary care settings. Notably, a recent study involving 25,000 
patients in primary care clinics described a structured quality-improvement 
based approach to increase recognition, treatment, and outcomes for patients 
with MDD.4 This broad study emphasized systematic measurement-based care 
(MBC), which guided clinicians throughout the whole process of screening and 
treatment to ultimately improve outcomes for those with MDD. This study 
demonstrates that, when adopted, MBC is an effective tool to guide clinicians 
through the process of caring for MDD in the primary care setting.5
While there are a handful of journal publications examining how depression 
screening has been implemented in the primary care setting. Overall, however, 
there is still a dearth of published data which outlines clear interventions to 
improve depression screening rates using a quality-improvement model. More 
work needs to be done to outline clear effective interventions that improve 
screening and lead to improved intervention and treatment for patients with 
MDD in the primary care setting.  
Problem Statement
At PMG Southeast Family Medicine depression screening rates, averaged 50-
55% in 2018. Given that our population likely experiences higher rates of 
depression than the national average, aiming to improve our screening rates 
would result in improved recognition and treatment of this common mental 
health problem.
Project Aim
We aim to improve rates of depression screening in eligible 
patients 12 years and older as measured by Patient Health 
Questionaire-2 (PHQ-2) within the last 365 days to 63% by 
March 1, 2020. 1. Maurer D, Raymond T, Davis B. Am Fam Physician. 2018 Oct 15;98(8):508-515.
2. Parchman, M. L. (1991, September). Recognition of depression in patients who smoke. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/1880483
3. Vieira, E. R., PhD, Brown, E., EdD, & Raue, P., PhD. (n.d.). Depression in Older Adults: Screening and Referral : Journal of Geriatric Physical Therapy. Retrieved from
https://journals.lww.com/jgpt/fulltext/2014/01000/Depression_in_Older_Adults___Screening_and.4.aspx.
4. Arroll, B., Goodyear-Smith, F., Crengle, S., Gunn, J., Kerse, N., Fishman, T., . . . Hatcher, S. (2010). Validation of PHQ-2 and PHQ-9 to Screen for Major Depression in 
the Primary Care Population. The Annals of Family Medicine, 8(4), 348-353. doi:10.1370/afm.1139
5. Jha MK, Grannemann BD, Trombello JM, et al. A Structured Approach to Detecting and Treating Depression in Primary Care: VitalSign6 Project. Ann Fam Med. 
2019;17(4):326-335.
It is important to note that these historical performance benchmarks are selected by 
internal committees by the OHA and necessarily based on clinical/population studies 
aimed at setting a specific screening target threshold that would improve clinical 
outcomes. Rather, performance benchmarks for this metric are defined by relative 
clinic performance across participating clinics.  These relative performance 
benchmarks are helpful, however, as it provides a reference point of depression 
screening rates that are achievable within the context of a busy primary care clinic.  
We did not achieve our aim of 63% with our planned interventions. However, we did 
increase the clinic’s overall percentage of patient’s screened (+1.7%) prior to the 
onset of the COVID19 pandemic in Oregon with, practically, two PDSA cycles only. It 
appears our interventions had a likely cumulative affect and thus continued tweaks to 
clinic practice and workflow with additional PDSA cycles would bring the clinic closer 
to this goal.
Data
Results
 Intervention #1 (PDSA cycle 1 – all patients receive laminated PHQ2 at check-in) yielded the 
greatest increase in percentage of patients screened (+ 1.2%). However, we received anecdotal 
feedback that frequent clinic visitors were overwhelmed by repeated screens.
 Intervention #2 (PDSA cycle 2 – pre-half-day huddle to identify patients for screening) resulted in 
a loss of percentage points (-0.05%). This was likely due to inconsistent implementation by 
providers and MAs.
 Intervention #3 (PDSA cycle 3 – checklist reminder to improve consistency in pre-half-day huddle 
to identify patients for screening) was difficult to truly evaluate because its implementation 
coincided with the disruption to routine clinic practice by the COVID19 pandemic.
 Balancing Measures: to track if in-clinic workflow changes effected other screening processes 
and to ensure that our primary outcome change was more likely a result of our project-specific 
changes, we tracked SBIRT screening during our QI project.  Our clinic SBIRT screening rates 
remained flat throughout the months of our PDSAs suggesting that our activities neither had a 
negative effect on other MA-driven screening processes, nor were effected by inherent changes 
within clinic workflow unrelated to our project. 
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Understanding the Problem
Current Process
Fishbone Diagram
Swim Diagram
Root Cause Synthesis
In completing our swim diagram and fishbone we have identified that current clinical 
processes have inconsistencies which increased the likelihood that the depression 
screenings are either not completed or rather the data is not entered into the EHR. Two 
main inconsistencies have been identified.  First, the primary way this data is collected is 
either by a purple sheet handed out by the front desk or by the MA.  Further identifying 
who receives a purple sheet and who does not as well as creating a standard process for 
all those patients >12 that should be getting screened may improve current screening 
rates. The other primary inconsistency is screening data entry into EHR. Data is often 
entered by the MA however sometimes it is the physician/provider. This process could be 
improved by ensuring a uniform way this information is entered every time and that the 
data collected from the purple sheets is always entered prior to handing the purple sheet 
to the provider.
Methods
We completed three Plan, Do, Study, Act (PDSA) cycles to achieve the project aim, 
focusing on identifying our available clinic data on screening patients for depression using 
the PHQ-2 tool, compiling this data into a useable form, developing and implementing 
interventions, and evaluating the effect of these interventions. 
PDSA 1:
- Plan: Front desk gives laminated PHQ-2 to all patients.
- Do: Developed and produced laminated PHQ-2 form, reviewed change in workflow 
with front desk and MAs.
- Study: Evaluated change in percentage patients screened; solicited feedback from 
front desk and MAs regarding effect on patients and rooming process.
- Act: Integrated anecdotal findings into development of next PDSA cycle.
PDSA 2:
- Plan: MAs will review Healthy Planet for each patient on provider’s schedule, with goal 
of identifying those currently due for PHQ-2 as well as those due for screening within 
the next 6 months.
- Do: Reviewed workflow at All Staff meeting and reinforced during huddles held at the 
beginning of the half day.
- Study: Evaluated change in percentage patients screened; solicited feedback from 
staff regarding effect on patients and rooming process.
- Act: Integrated anecdotal findings into development of next PDSA cycle.
PDSA 3:
- Plan: Create checklist for MA rooming process and provider reminder to check when 
depression screening was last done, and to screen if >6m.
- Do: Developed and produced checklist, sent checklist to clinic managers for approval, 
print and laminated 18 copies for each exam room, checklist posted to all computers.
- Study: Evaluated change in percentage patients screened, solicited feedback from 
staff regarding effect on patients and rooming process.
- Act: Evaluated total effect of three PDSAs to develop recommendation for screening 
workflow for clinic.
PMG primary care clinics have been tracking 
rates of depression screening since 2013.  
Depression screening is an established 
nation-wide quality metric recognized by CMS 
and the National Quality Forum and is among 
the health metrics utilized by the 
Comprehensive Primary Care to track primary 
care quality among participating clinics. Data 
on eligible patients screened were pulled from 
Healthy Planet monthly in order to assess the 
effect of PDSA interventions.
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